2 deals
Psychedelic biotech startup Psylo raises $5 million Seed round
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.